No Change in Screening Rates Since USPSTF Mammography Recommendations

This article originally appeared here.
Share this content:
Mammogram Rates Unchanged Since USPSTF Recommendations
Mammogram Rates Unchanged Since USPSTF Recommendations

(HealthDay News) -- There has been no change in mammography screening rates among women aged 40 years or older following publication of the 2009 U.S. Preventive Services Task Force (USPSTF) recommendations, according to research published online April 19 in Cancer.

Lydia E. Pace, M.D., M.P.H., from Brigham and Women's Hospital in Boston, and colleagues examined the impact of the 2009 USPSTF recommendations on mammography screening patterns among women age 40 to 49 years and 50 to 74 years. Data on mammography use were reviewed for 27,829 women aged 40 years or older from the National Health Interview Survey for 2005, 2008, and 2011.

The researchers observed a non-significant increase in mammography screening rates, from 51.9% in 2008 to 53.6% in 2011 (P = 0.07), after adjustment for race, income, education level, insurance, and immigration status. There were no declines noted among any age groups. The screening rates were 46.1% in 2008 and 47.5% in 2011 among women aged 40 to 49 years (P = 0.38), and the corresponding rates were 57.2% and 59.1% for women aged 50 to 74 years (P = 0.09).

"In conclusion, we observed no decrease in mammography rates for women aged >40 years after publication of the USPSTF recommendations in 2009," the authors write. "Whether through their impact on patients, providers, or both, it seems that the vigorous policy debates and coverage in the media and medical literature have limited adoption of these recommendations."

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs